<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114489">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02136667</url>
  </required_header>
  <id_info>
    <org_study_id>98372017</org_study_id>
    <nct_id>NCT02136667</nct_id>
  </id_info>
  <brief_title>Preeclampsia and Circulating Biomarkers</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Randers Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karen Elise Jensens Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Denmark Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to assess circulating biomarkers of cardiovascular risk, we will conduct a 10-year
      follow-up study comparing 32 exposed (women with a history of pregnancy complicated by
      preeclampsia) and 32 unexposed (women with a history of uncomplicated pregnancy).

      Participants will be recruited from a well-characterised cohort, previously assembled during
      their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in
      2001-2004.

      Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus
      rendering the possibility of longitudinal assessment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Circulating biomarkers of cardiovascular disease 10 years postpartum.</measure>
    <time_frame>10 years postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Markers of arteriosclerosis and atherosclerosis</measure>
    <time_frame>10 years postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulating biomarkers of cardiovascular disease at baseline pregnancy.</measure>
    <time_frame>During pregnancy</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Postpartum CVD Risk in Women With Previous Preeclampsia.</condition>
  <arm_group>
    <arm_group_label>Exposed</arm_group_label>
    <description>Women with a history of preeclampsia 10 years ago</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unexposed</arm_group_label>
    <description>Women with a history of uncomplicated pregnancy 10 years ago</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood serum Blood plasma Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited from a well-characterised cohort, previously assembled at
        the Department of Obstetrics at Randers Regional Hospital in 2001-2005.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation in previous study 2001-2005.

        Exclusion Criteria:

          -  Current pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulla B Knudsen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynaecology, Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Christensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Unit, Randers Regional Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Camilla S Kronborg, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Oncology, Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Randers Regional Hospital</name>
      <address>
        <city>Randers</city>
        <state>Randers NÃ˜</state>
        <zip>8930</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Christensen, MD</last_name>
      <phone>004578422354</phone>
      <email>marticis@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Martin Christensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>May 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preeclampsia</keyword>
  <keyword>Cardiovascular disease (CVD) risk</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
